Cover Image
市場調查報告書

女性的健康的全球市場 - 產業分析,市場規模,佔有率,成長,趨勢,預測(2017年∼2025年)

Women's Health Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2025

出版商 Transparency Market Research 商品編碼 603275
出版日期 內容資訊 英文 180 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
女性的健康的全球市場 - 產業分析,市場規模,佔有率,成長,趨勢,預測(2017年∼2025年) Women's Health Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2025
出版日期: 2018年01月09日 內容資訊: 英文 180 Pages
簡介

本報告提供女性的健康的全球市場調查,市場概要,各治療類型、對象疾病、地區的市場趨勢,市場規模的變化與預測,市場成長、阻礙因素以及市場機會分析,市場佔有率,競爭情形,主要企業的簡介等,全面性資訊。

目錄

第1章 簡介

  • 報告範圍和市場區隔
  • 調查的重點

第2章 前提和調查方法

  • 前提條件
  • 縮寫
  • 調查方法

第3章 摘要整理

  • 市場概述

第4章 女性的健康的全球市場:概要

  • 市場概況
  • 市場機會藍圖
  • 主要產業活動
  • 市場規模的變化與預測
  • 市場預測
  • 開發平台分析
  • 主要趨勢
  • 政府的積極推動/主要投資評估

第5章 市場動態

  • 成長、阻礙因素分析
  • 成長要素
  • 阻礙因素
  • 市場機會

第6章 女性的健康的全球市場:各治療類型

  • 簡介
  • 重要考察
  • 市場佔有率分析:各治療類型
  • 市場預測:各治療類型
    • 荷爾蒙治療
    • 非荷爾蒙治療
  • 市場魅力分析:各治療類型
  • 主要趨勢

第7章 女性的健康的全球市場:各對象疾病

  • 簡介
  • 重要考察
  • 市場佔有率分析:各對象疾病
  • 市場預測:各對象疾病
    • 癌症
    • 甲狀腺機能低下症
    • 閉經
    • 骨質疏鬆症
    • 不孕
    • 子宮肌瘤
    • 尿道感染
  • 市場魅力分析:各對象疾病
  • 主要趨勢

第8章 女性的健康的全球市場:各地區

  • 市場規模分析:各地區
  • 市場預測:各地區
    • 北美
    • 歐洲
    • 亞太地區
    • 南美
    • 中東、非洲

第9章 北美

第10章 歐洲

第11章 亞太地區

第12章 南美

第13章 中東、非洲

第14章 競爭情形

  • 企業的市場定位
  • 競爭分析
  • 企業簡介
    • Eli Lilly and Company
    • Novartis AG
    • Pfizer, Inc.
    • Merck & Co., Inc.
    • Novo Nordisk A/S
    • Amgen Inc.
    • AstraZeneca
    • F. Hoffmann-La Roche Ltd.
    • Sanofi
    • Allergan Plc
    • GlaxoSmithKline plc
    • Lupin Pharmaceuticals, Inc.
目錄

Title:
Women's Health Market (Treatment Type - Hormonal Treatment (Estrogen Therapy, Progestin Therapy, Combination Therapy, Thyroid Replacement Therapy, Parathyroid Hormone Therapy, and Others) and Non-Hormonal Treatment (Targeted Therapy Drugs, Antibiotics, Bisphosphonates, and Others); Disease Indication - Cancer (Breast Cancer, Cervical Cancer, Ovarian Cancer), Hypothyroidism, Post-Menopausal Syndrome, Osteoporosis, Contraceptive, Uterine Fibroid, Urinary Tract Infection, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2025.

Global Women's Health Market: Overview

This report on the women's health market analyzes the current and future scenario of the global market. Rise in number of women facing menopausal condition, rising incidence of women's diseases, growing awareness among people about the availability of treatment for women's health related diseases, technological advancements and high R&D investments are major factors driving market growth.

The women's health market report comprises an elaborate executive summary, which includes a market snapshot that provides information about various segments of the market. It also provides information and data analysis of the global market with respect to the segments based on treatment type, disease indication, and geography. A detailed qualitative analysis of drivers and restraints of the market and opportunities has been provided in the market overview section. In addition, the section comprises competitive matrix and company profiles with business overview to understand the competitive landscape in the market. This section of the report also provides market attractiveness analysis, by geography and market share analysis by key players, thus presenting a thorough analysis of the overall competitive scenario in the women's health market.

Global Women's Health Market: Segmentation

Based on treatment type, the market has been segmented into hormonal treatment and non-hormonal treatment. Hormonal treatment segment is subdivided into estrogen therapy, progestin therapy, combination therapy, thyroid replacement therapy, parathyroid hormone therapy, and others. While non-hormonal treatment segment considers cancer targeted therapy drugs, antibiotics, bisphosphonates, and others (vitamin D treatment, calcitonin, RANK-Ligand, non-steroidal anti-inflammatory drugs etc.). The treatment type market segments have been analyzed based on available approved drugs, cost-effectiveness, and prevalence rate by geography. The market size in terms of value (US$) and forecast for each of these segments have been provided for the period from 2015 to 2025, along with their respective CAGRs for the forecast period from 2017 to 2025, considering 2016 as the base year.

Based on disease indication, the women's health market has been segmented into following categories: cancer, hypothyroidism, post-menopausal syndrome, osteoporosis, contraceptive, uterine fibroid, urinary tract infection, and other disease indications. The market segments have been extensively analyzed based on new product launches, incidence and prevalence rate, and prescription pattern. The market size and forecast in terms of US$ Mn for each segment have been provided for the period from 2015 to 2025. The report also provides the compound annual growth rate (CAGR %) for each market segment for the forecast period from 2017 to 2025, considering 2016 as the base year.

Global Women's Health Market: Regional Outlook

Geographically, the global women's health market has been categorized into five major regions and the key countries in the respective region: North America (the U.S., Canada), Europe (the U.K., Germany, France, Spain, Italy, and Rest of Europe), Asia Pacific (India, China, Japan, Australia & New Zealand and Rest of Asia Pacific), Latin America (Brazil, Mexico, and Rest of Latin America) and Middle East & Africa (South Africa, GCC countries and Rest of Middle East & Africa). The market size and forecast for each of these regions and the mentioned countries have been provided for the period from 2015 to 2025, along with their respective CAGRs for the forecast period from 2017 to 2025, considering 2016 as the base year. The research study also covers the competitive scenario in these regions.

Competitive Landscape

The report also profiles major players in the global women's health market based on various attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments. The major players in the women's health market are - Eli Lilly and Company, Novartis AG, Pfizer, Inc., Merck & Co., Inc., Novo Nordisk A/S, Amgen Inc., Lupin Pharmaceuticals, Inc., AstraZeneca, F. Hoffmann-La Roche Ltd., Sanofi, Allergan Plc, Bayer AG, GlaxoSmithKline plc, and Johnson & Johnson and others.

The global women's health market is segmented as given below:

Global Women's Health Market, by Treatment Type:

  • Hormonal Treatment
    • Estrogen Therapy
    • Progestin Therapy
    • Combination Therapy
    • Thyroid Replacement Therapy
    • Parathyroid Hormone Therapy
    • Others
  • Non-Hormonal Treatment
    • Targeted Therapy Drugs
    • Antibiotics
    • Bisphosphonates
    • Others

Global Women's Health Market, by Disease Indication:

  • Cancer
  • Breast Cancer
  • Cervical Cancer
  • Ovarian Cancer
  • Hypothyroidism
  • Post-Menopausal Syndrome
  • Osteoporosis
  • Contraceptive
  • Uterine Fibroid
  • Urinary Tract Infection
  • Others

Global Women's Health Market, by Geography:

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Spain
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia and New Zealand
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • South Africa
    • GCC Countries
    • Rest of MEA

Table of Contents

1. Preface

  • 1.1. Report Scope and Market Segmentation
  • 1.2. Research Highlights

2. Assumptions and Research Methodology

  • 2.1. Assumptions
  • 2.2. Acronyms Used
  • 2.3. Research Methodology

3. Executive Summary

  • 3.1. Global Women's Health Market Snapshot

4. Market Overview

  • 4.1. Market Overview
  • 4.2. Market Opportunity Map
  • 4.3. Key Industry Events
  • 4.4. Global Women's Health Market Size (US$ Mn) Forecast, 2015-2025
  • 4.5. Global Women's Health Market Outlook
  • 4.6. Pipeline Analysis
  • 4.7. Key Trends
  • 4.8. Government Initiatives/Key Investments Assessment

5. Market Dynamics

  • 5.1. Drivers and Restraints Snapshot Analysis
  • 5.2. Drivers
  • 5.3. Restraints
  • 5.4. Opportunities

6. Global Women's Health Market Analysis, by Treatment Type

  • 6.1. Introduction
  • 6.2. Key Insights
  • 6.3. Global Women's Health Market Value Share Analysis, by Treatment Type
  • 6.4. Global Women's Health Market Forecast, by Treatment Type
    • 6.4.1. Hormonal
      • 6.4.1.1. Estrogen
      • 6.4.1.2. Progestin
      • 6.4.1.3. Combination
      • 6.4.1.4. Parathyroid
      • 6.4.1.5. Thyroid
      • 6.4.1.6. Others
    • 6.4.2. Non-Hormonal
      • 6.4.2.1. Targeted Drugs
      • 6.4.2.2. Antibiotics
      • 6.4.2.3. Biphosphonates
      • 6.4.2.4. Others
  • 6.5. Global Women's Health Market Attractiveness Analysis, by Treatment Type
  • 6.6. Key Trends

7. Global Women's Health Market Analysis, by Disease Indication

  • 7.1. Introduction
  • 7.2. Key Insights
  • 7.3. Global Women's Health Market Value Share Analysis, by Treatment Type
  • 7.4. Global Women's Health Market Forecast, by Treatment Type
    • 7.4.1. Cancer
      • 7.4.1.1. Breast Cancer
      • 7.4.1.2. Cervical Cancer
      • 7.4.1.3. Ovarian Cancer
    • 7.4.2. Hypothyroidism
    • 7.4.3. Menopause
    • 7.4.4. Osteoporosis
    • 7.4.5. Contraceptive
    • 7.4.6. Uterine Fibroid
    • 7.4.7. Urinary Tract Infection
  • 7.5. Global Women's Health Market Attractiveness Analysis, by Treatment Type
  • 7.6. Key Trends

8. Global Women's Health Market Analysis, by Region

  • 8.1. Global Women's Health Market Value Share Analysis, by Region
  • 8.2. Global Women's Health Market Forecast, by Region, 2015-2025
    • 8.2.1. North America
    • 8.2.2. Europe
    • 8.2.3. Asia Pacific
    • 8.2.4. Latin America
    • 8.2.5. Middle East & Africa

9. North America Women's Health Market Analysis

  • 9.1. North America Women's Health Market Overview
  • 9.2. North America Women's Health Market Value Share Analysis, by Treatment Type
  • 9.3. North America Women's Health Market Value Share Analysis, by Disease Indication
  • 9.4. North America Women's Health Market Value Share Analysis, by Country
  • 9.5. North America Women's Health Market Forecast, by Treatment Type
    • 9.5.1. Hormonal
      • 9.5.1.1. Estrogen
      • 9.5.1.2. Progestin
      • 9.5.1.3. Combination
      • 9.5.1.4. Parathyroid
      • 9.5.1.5. Thyroid
      • 9.5.1.6. Others
    • 9.5.2. Non-Hormonal
      • 9.5.2.1. Targeted Drugs
      • 9.5.2.2. Antibiotics
      • 9.5.2.3. Biphosphonates
      • 9.5.2.4. Others
  • 9.6. North America Women's Health Market Forecast, by Disease Indication
    • 9.6.1. Cancer
      • 9.6.1.1. Breast Cancer
      • 9.6.1.2. Cervical Cancer
      • 9.6.1.3. Ovarian Cancer
    • 9.6.2. Hypothyroidism
    • 9.6.3. Menopause
    • 9.6.4. Osteoporosis
    • 9.6.5. Contraceptive
    • 9.6.6. Uterine Fibroid
    • 9.6.7. Urinary Tract Infection
  • 9.7. North America Women's Health Market Forecast, by Country
    • 9.7.1. United States
    • 9.7.2. Canada
  • 9.8. North America Women's Health Market Attractiveness Analysis,
    • 9.8.1. By Treatment Type
    • 9.8.2. By Disease Indication
    • 9.8.3. By Country
  • 9.9. North America - Key Trends

10. Europe Women's Health Market Analysis

  • 10.1. Europe Women's Health Market Overview
  • 10.2. Europe Women's Health Market Value Share Analysis, by Treatment Type
  • 10.3. Europe Women's Health Market Value Share Analysis, by Disease Indication
  • 10.4. Europe Women's Health Market Value Share Analysis, by Country
  • 10.5. Europe Women's Health Market Forecast, by Treatment Type
    • 10.5.1. Hormonal
      • 10.5.1.1. Estrogen
      • 10.5.1.2. Progestin
      • 10.5.1.3. Combination
      • 10.5.1.4. Parathyroid
      • 10.5.1.5. Thyroid
      • 10.5.1.6. Others
    • 10.5.2. Non-Hormonal
      • 10.5.2.1. Targeted Drugs
      • 10.5.2.2. Antibiotics
      • 10.5.2.3. Biphosphonates
      • 10.5.2.4. Others
  • 10.6. Europe Women's Health Market Forecast, by Disease Indication
    • 10.6.1. Cancer
      • 10.6.1.1. Breast Cancer
      • 10.6.1.2. Cervical Cancer
      • 10.6.1.3. Ovarian Cancer
    • 10.6.2. Hypothyroidism
    • 10.6.3. Menopause
    • 10.6.4. Osteoporosis
    • 10.6.5. Contraceptive
    • 10.6.6. Uterine Fibroid
    • 10.6.7. Urinary Tract Infection
  • 10.7. Europe Women's Health Market Forecast, by Country / Sub-region
    • 10.7.1. UK
    • 10.7.2. Germany
    • 10.7.3. France
    • 10.7.4. Italy
    • 10.7.5. Spain
    • 10.7.6. Rest of Europe
  • 10.8. Europe Women's Health Market Attractiveness Analysis
    • 10.8.1. By Treatment Type
    • 10.8.2. By Disease Indication
    • 10.8.3. By Country / Sub-region
  • 10.9. Europe - Key Trends

11. Asia Pacific Women's Health Market Analysis

  • 11.1. Asia Pacific Women's Health Market Overview
  • 11.2. Asia Pacific Women's Health Market Value Share Analysis, by Treatment Type
  • 11.3. Asia Pacific Women's Health Market Value Share Analysis, by Disease Indication
  • 11.4. Asia Pacific Women's Health Market Value Share Analysis, by Country
  • 11.5. Asia Pacific Women's Health Market Forecast, by Treatment Type
    • 11.5.1. Hormonal
      • 11.5.1.1. Estrogen
      • 11.5.1.2. Progestin
      • 11.5.1.3. Combination
      • 11.5.1.4. Parathyroid
      • 11.5.1.5. Thyroid
      • 11.5.1.6. Others
    • 11.5.2. Non-Hormonal
      • 11.5.2.1. Targeted Drugs
      • 11.5.2.2. Antibiotics
      • 11.5.2.3. Biphosphonates
      • 11.5.2.4. Others
  • 11.6. Asia Pacific Women's Health Market Forecast, by Disease Indication
    • 11.6.1. Cancer
      • 11.6.1.1. Breast Cancer
      • 11.6.1.2. Cervical Cancer
      • 11.6.1.3. Ovarian Cancer
    • 11.6.2. Hypothyroidism
    • 11.6.3. Menopause
    • 11.6.4. Osteoporosis
    • 11.6.5. Contraceptive
    • 11.6.6. Uterine Fibroid
    • 11.6.7. Urinary Tract Infection
  • 11.7. Asia Pacific Women's Health Market Forecast, by Country / Sub-region
    • 11.7.1. China
    • 11.7.2. Japan
    • 11.7.3. India
    • 11.7.4. Australia
    • 11.7.5. Rest of APAC
  • 11.8. Asia Pacific Women's Health Market Attractiveness Analysis
    • 11.8.1. By Treatment Type
    • 11.8.2. By Disease Indication
    • 11.8.3. By Country / Sub-region
  • 11.9. Asia Pacific - Key Trends

12. Latin America Women's Health Market Analysis

  • 12.1. Latin America Women's Health Market Overview
  • 12.2. Latin America Women's Health Market Value Share Analysis, by Treatment Type
  • 12.3. Latin America Women's Health Market Value Share Analysis, by Disease Indication
  • 12.4. Latin America Women's Health Market Value Share Analysis, by Country
  • 12.5. Latin America Women's Health Market Forecast, by Treatment Type
    • 12.5.1. Hormonal
      • 12.5.1.1. Estrogen
      • 12.5.1.2. Progestin
      • 12.5.1.3. Combination
      • 12.5.1.4. Parathyroid
      • 12.5.1.5. Thyroid
      • 12.5.1.6. Others
    • 12.5.2. Non-Hormonal
      • 12.5.2.1. Targeted Drugs
      • 12.5.2.2. Antibiotics
      • 12.5.2.3. Biphosphonates
      • 12.5.2.4. Others
  • 12.6. Latin America Women's Health Market Forecast, by Disease Indication
    • 12.6.1. Cancer
      • 12.6.1.1. Breast Cancer
      • 12.6.1.2. Cervical Cancer
      • 12.6.1.3. Ovarian Cancer
    • 12.6.2. Hypothyroidism
    • 12.6.3. Menopause
    • 12.6.4. Osteoporosis
    • 12.6.5. Contraceptive
    • 12.6.6. Uterine Fibroid
    • 12.6.7. Urinary Tract Infection
  • 12.7. Latin America Women's Health Market Forecast, by Country / Sub-region
    • 12.7.1. Brazil
    • 12.7.2. Mexico
    • 12.7.3. Rest of Latin America
  • 12.8. Latin America Women's Health Market Attractiveness Analysis
    • 12.8.1. By Treatment Type
    • 12.8.2. By Disease Indication
    • 12.8.3. By Country / Sub-region
  • 12.9. Latin America - Key Trends

13. Middle East & Africa Women's Health Market Analysis

  • 13.1. Middle East & Africa Women's Health Market Overview
  • 13.2. Middle East & Africa Women's Health Market Value Share Analysis, by Treatment Type
  • 13.3. Middle East & Africa Women's Health Market Value Share Analysis, by Disease Indication
  • 13.4. Middle East & Africa Women's Health Market Value Share Analysis, by Country
  • 13.5. Middle East & Africa Women's Health Market Forecast, by Treatment Type
    • 13.5.1. Hormonal
      • 13.5.1.1. Estrogen
      • 13.5.1.2. Progestin
      • 13.5.1.3. Combination
      • 13.5.1.4. Parathyroid
      • 13.5.1.5. Thyroid
      • 13.5.1.6. Others
    • 13.5.2. Non-Hormonal
      • 13.5.2.1. Targeted Drugs
      • 13.5.2.2. Antibiotics
      • 13.5.2.3. Biphosphonates
      • 13.5.2.4. Others
  • 13.6. Middle East & Africa Women's Health Market Forecast, by Disease Indication
    • 13.6.1. Cancer
      • 13.6.1.1. Breast Cancer
      • 13.6.1.2. Cervical Cancer
      • 13.6.1.3. Ovarian Cancer
    • 13.6.2. Hypothyroidism
    • 13.6.3. Menopause
    • 13.6.4. Osteoporosis
    • 13.6.5. Contraceptive
    • 13.6.6. Uterine Fibroid
    • 13.6.7. Urinary Tract Infection
  • 13.7. Middle East & Africa Women's Health Market Forecast, by Country / Sub-region
    • 13.7.1. GCC Countries
    • 13.7.2. South Africa
    • 13.7.3. Rest of Middle East & Africa
  • 13.8. Middle East & Africa Women's Health Market Attractiveness Analysis
    • 13.8.1. By Treatment Type
    • 13.8.2. By Disease Indication
    • 13.8.3. By Country / Sub-region
  • 13.9. Middle East & Africa - Key Trends

14. Competition Landscape

  • 14.1. Competitive Positioning
  • 14.2. Competition Matrix
  • 14.3. Company Profiles
    • 14.3.1. Eli Lilly and Company
      • 14.3.1.1. Overview (HQ, Employee Strength, Business Segments)
      • 14.3.1.2. Financials
      • 14.3.1.3. Recent Developments
      • 14.3.1.4. Strategy
    • 14.3.2. Novartis AG
      • 14.3.2.1. Overview (HQ, Employee Strength, Business Segments)
      • 14.3.2.2. Financials
      • 14.3.2.3. Recent Developments
      • 14.3.2.4. Strategy
    • 14.3.3. Pfizer, Inc.
      • 14.3.3.1. Overview (HQ, Employee Strength, Business Segments)
      • 14.3.3.2. Financials
      • 14.3.3.3. Recent Developments
      • 14.3.3.4. Strategy
    • 14.3.4. Merck & Co., Inc.
      • 14.3.4.1. Overview (HQ, Employee Strength, Business Segments)
      • 14.3.4.2. Financials
      • 14.3.4.3. Recent Developments
      • 14.3.4.4. Strategy
    • 14.3.5. Novo Nordisk A/S
      • 14.3.5.1. Overview (HQ, Employee Strength, Business Segments)
      • 14.3.5.2. Financials
      • 14.3.5.3. Recent Developments
      • 14.3.5.4. Strategy
    • 14.3.6. Amgen Inc.
      • 14.3.6.1. Overview (HQ, Employee Strength, Business Segments)
      • 14.3.6.2. Financials
      • 14.3.6.3. Recent Developments
      • 14.3.6.4. Strategy
    • 14.3.7. AstraZeneca
      • 14.3.7.1. Overview (HQ, Employee Strength, Business Segments)
      • 14.3.7.2. Financials
      • 14.3.7.3. Recent Developments
      • 14.3.7.4. Strategy
    • 14.3.8. F. Hoffmann-La Roche Ltd.
      • 14.3.8.1. Overview (HQ, Employee Strength, Business Segments)
      • 14.3.8.2. Financials
      • 14.3.8.3. Recent Developments
      • 14.3.8.4. Strategy
    • 14.3.9. Sanofi
      • 14.3.9.1. Overview (HQ, Employee Strength, Business Segments)
      • 14.3.9.2. Financials
      • 14.3.9.3. Recent Developments
      • 14.3.9.4. Strategy
    • 14.3.10. Allergan Plc
      • 14.3.10.1. Overview (HQ, Employee Strength, Business Segments)
      • 14.3.10.2. Financials
      • 14.3.10.3. Recent Developments
      • 14.3.10.4. Strategy
    • 14.3.11. GlaxoSmithKline plc
      • 14.3.11.1. Overview (HQ, Employee Strength, Business Segments)
      • 14.3.11.2. Financials
      • 14.3.11.3. Recent Developments
      • 14.3.11.4. Strategy
    • 14.3.12. Lupin Pharmaceuticals, Inc.
      • 14.3.12.1. Overview (HQ, Employee Strength, Business Segments)
      • 14.3.12.2. Financials
      • 14.3.12.3. Recent Developments
      • 14.3.12.4. Strategy

List of Tables

  • TABLE 1 Global Women's Health Market Size (US$ Mn) Forecast, by Treatment Type, 2015-2025
  • TABLE 2 Global Women's Health Market Size (US$ Mn) Forecast, by Treatment Type - Hormonal Treatment, 2015-2025
  • TABLE 3 Global Women's Health Market Revenue (US$ Mn) and Y-o-Y (%) Forecast, by Hormonal Treatment
  • TABLE 4 Global Women's Health Market Revenue (US$ Mn) and Y-o-Y (%) Forecast, by Estrogen Treatment
  • TABLE 5 Global Women's Health Market Revenue (US$ Mn) and Y-o-Y (%) Forecast, by Progestin Treatment
  • TABLE 6 Global Women's Health Market Revenue (US$ Mn) and Y-o-Y (%) Forecast, by Combination Treatment
  • TABLE 7 Global Women's Health Market Revenue (US$ Mn) and Y-o-Y (%) Forecast, by Thyroid Treatment
  • TABLE 8 Global Women's Health Market Revenue (US$ Mn) and Y-o-Y (%) Forecast, by Parathyroid Treatment
  • TABLE 9 Global Women's Health Market Revenue (US$ Mn) and Y-o-Y (%) Forecast, by Others Treatment
  • TABLE 10 Global Women's Health Market Revenue (US$ Mn) and Y-o-Y (%) Forecast, by Non-Hormonal Treatment
  • TABLE 11 Global Women's Health Market Revenue (US$ Mn) and Y-o-Y (%) Forecast, by Targeted Therapy Drugs Treatment
  • TABLE 12 Global Women's Health Market Revenue (US$ Mn) and Y-o-Y (%) Forecast, by Antibiotics Therapy Drugs
  • TABLE 13 Global Women's Health Market Revenue (US$ Mn) and Y-o-Y (%) Forecast, by Bisphosphonate Therapy Drugs
  • TABLE 14 Global Women's Health Market Size (US$ Mn) Forecast, by Treatment Type - Non-Hormonal Treatment, 2015-2025
  • TABLE 15 Global Women's Health Market Size (US$ Mn) Forecast, by Disease Indication, 2015-2025
  • TABLE 16 Global Women's Health Market Size (US$ Mn) Forecast, by Region, 2015-2025
  • TABLE 17 North America Women's Health Market Size (US$ Mn) Forecast, by Country, 2015-2025
  • TABLE 18 North America Women's Health Market Size (US$ Mn) Forecast, by Treatment Type, 2015-2025
  • TABLE 19 North America Women's Health Market Size (US$ Mn) Forecast, by Hormonal Treatment, 2015-2025
  • TABLE 20 North America Women's Health Market Size (US$ Mn) Forecast, by Non-hormonal Treatment, 2015-2025
  • TABLE 21 North America Women's Health Market Size (US$ Mn) Forecast, by Disease Indication, 2015-2025
  • TABLE 22 Europe Women's Health Market Size (US$ Mn) Forecast, by Country, 2015-2025
  • TABLE 23 Europe Women's Health Market Size (US$ Mn) Forecast, by Treatment Type, 2015-2025
  • TABLE 24 Europe Women's Health Market Size (US$ Mn) Forecast, by Treatment Type - Hormonal Treatment, 2015-2025
  • TABLE 25 Europe Women's Health Market Size (US$ Mn) Forecast, by Treatment Type - Non-Hormonal Treatment, 2015-2025
  • TABLE 26 Europe Women's Health Market Size (US$ Mn) Forecast, by Disease Indication, 2015-2025
  • TABLE 27 Asia Pacific Women's Health Market Size (US$ Mn) Forecast, by Country, 2015-2025
  • TABLE 28 Asia Pacific Women's Health Market Size (US$ Mn) Forecast, by Treatment Type, 2015-2025
  • TABLE 29 Asia Pacific Women's Health Market Size (US$ Mn) Forecast, by Hormonal Treatment, 2015-2025
  • TABLE 30 Asia Pacific Women's Health Market Size (US$ Mn) Forecast, by Non-hormonal Treatment, 2015-2025
  • TABLE 31 Asia Pacific Women's Health Market Size (US$ Mn) Forecast, by Disease Indication, 2015-2025
  • TABLE 32 Latin America Women's Health Market Size (US$ Mn) Forecast, by Country, 2015-2025
  • TABLE 33 Latin America Women's Health Market Size (US$ Mn) Forecast, by Treatment Type, 2015-2025
  • TABLE 34 Latin America Women's Health Market Size (US$ Mn) Forecast, by Treatment Type - Hormonal Treatment, 2015-2025
  • TABLE 35 Latin America Women's Health Market Size (US$ Mn) Forecast, by Treatment Type - Non-Hormonal Treatment, 2015-2025
  • TABLE 36 Latin America Women's Health Market Size (US$ Mn) Forecast, by Disease Indication, 2015-2025
  • TABLE 37 Middle East & Africa Women's Health Market Size (US$ Mn) Forecast, by Country, 2015-2025
  • TABLE 38 Middle East & Africa Women's Health Market Size (US$ Mn) Forecast, by Treatment Type, 2015-2025
  • TABLE 39 Middle East & Africa Women's Health Market Size (US$ Mn) Forecast, by Hormonal Treatment, 2015-2025
  • TABLE 40 Middle East & Africa Women's Health Market Size (US$ Mn) Forecast, by Non-hormonal Treatment, 2015-2025
  • TABLE 41 Middle East & Africa Women's Health Market Size (US$ Mn) Forecast, by Disease Indication, 2015-2025

List of Figures

  • FIG. 1 Global Women's Health Market Snapshot
  • FIG. 2 Revenue Share (2016)
  • FIG. 3 Key Industry Developments
  • FIG. 4 Porter's Analysis
  • FIG. 5 Value Chain Analysis
  • FIG. 6 Market Value Share, by Treatment Type (2016)
  • FIG. 7 Market Value Share, by Disease Indication (2016)
  • FIG. 8 Market Value Share, by Region (2016)
  • FIG. 9 Global Women's Health Market, by Treatment Type
  • FIG. 10 Global Women's Health Market Value Share Analysis, by Treatment Type, 2016 and 2025
  • FIG. 11 Global Women's Health Market Revenue (US$ Mn) and Y-o-Y (%) Forecast, by Hormonal Treatment
  • FIG. 12 Global Women's Health Market Revenue (US$ Mn) and Y-o-Y (%) Forecast, by Estrogen Treatment
  • FIG. 13 Global Women's Health Market Revenue (US$ Mn) and Y-o-Y (%) Forecast, by Progestin Treatment
  • FIG. 14 Global Women's Health Market Revenue (US$ Mn) and Y-o-Y (%) Forecast, by Combination Treatment
  • FIG. 15 Global Women's Health Market Revenue (US$ Mn) and Y-o-Y (%) Forecast, by Thyroid Treatment
  • FIG. 16 Global Women's Health Market Revenue (US$ Mn) and Y-o-Y (%) Forecast, by Parathyroid Treatment
  • FIG. 17 Global Women's Health Market Revenue (US$ Mn) and Y-o-Y (%) Forecast, by Others Treatment
  • FIG. 18 Global Women's Health Market Revenue (US$ Mn) and Y-o-Y (%) Forecast, by Non-Hormonal Treatment
  • FIG. 19 Global Women's Health Market Revenue (US$ Mn) and Y-o-Y (%) Forecast, by Targeted Therapy Drugs Treatment
  • FIG. 20 Global Women's Health Market Revenue (US$ Mn) and Y-o-Y (%) Forecast, by Antibiotics Therapy Drugs
  • FIG. 21 Global Women's Health Market Revenue (US$ Mn) and Y-o-Y (%) Forecast, by Bisphosphonate Therapy Drugs
  • FIG. 22 Global Women's Health Market Value Share Analysis, by Disease Indication, 2016 and 2025
  • FIG. 23 Global Women's Health Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Cancer
  • FIG. 24 Global Women's Health Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Hypothyroidism
  • FIG. 25 Global Women's Health Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Post-Menopausal Syndrome
  • FIG. 26 Global Women's Health Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Osteoporosis
  • FIG. 27 Global Women's Health Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Contraceptive
  • FIG. 28 Global Women's Health Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Uterine Fibroid (UF)
  • FIG. 29 Global Women's Health Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Urinary Tract Infection (UTI)
  • FIG. 30 Global Women's Health Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Others
  • FIG. 31 Global Market Scenario
  • FIG. 32 Global Women's Health Market Value Share Analysis, by Region, 2016 and 2025
  • FIG. 33 Global Women's Health Market Attractiveness Analysis, by Region
  • FIG. 34 North America Women's Health Market Size (US$ Mn) and Y-o-Y (%) Forecast, 2015-2025
  • FIG. 35 North America Women's Health Market Attractiveness Analysis, by Country, 2017-2025
  • FIG. 36 North America Women's Health Market Value Share Analysis, by Country, 2016 and 2025
  • FIG. 37 North America Women's Health Market Value Share Analysis, by Treatment Type, 2016 and 2025
  • FIG. 38 North America Women's Health Market Value Share Analysis, by Disease Indication, 2016 and 2025
  • FIG. 39 North America Women's Health Market Attractiveness Analysis, by Treatment Type, 2017-2025
  • FIG. 40 North America Women's Health Market Attractiveness Analysis, by Disease Indication, 2017-2025
  • FIG. 41 Europe Women's Health Market Size (US$ Mn) and Y-o-Y (%) Forecast, 2015-2025
  • FIG. 42 Europe Women's Health Market Attractiveness Analysis, by Country, 2017-2025
  • FIG. 43 Europe Women's Health Market Value Share Analysis, by Country, 2016 and 2025
  • FIG. 44 Europe Women's Health Market Value Share Analysis, by Treatment Type, 2016 and 2025
  • FIG. 45 Europe Women's Health Market Value Share Analysis, by Disease Indication, 2016 and 2025
  • FIG. 46 Europe Women's Health Market Attractiveness Analysis, by Treatment Type, 2017-2025
  • FIG. 47 Europe Women's Health Market Attractiveness Analysis, by Disease Indication, 2017-2025
  • FIG. 48 Asia Pacific Women's Health Market Size (US$ Mn) and Y-o-Y (%) Forecast, 2015-2025
  • FIG. 49 Asia Pacific Women's Health Market Attractiveness Analysis, by Country, 2017-2025
  • FIG. 50 Asia Pacific Women's Health Market Value Share Analysis, by Country, 2016 and 2025
  • FIG. 51 Asia Pacific Women's Health Market Value Share Analysis, by Treatment Type, 2016 and 2025
  • FIG. 52 Asia Pacific Women's Health Market Value Share Analysis, by Disease Indication, 2016 and 2025
  • FIG. 53 Asia Pacific Women's Health Market Attractiveness Analysis, by Treatment Type, 2017-2025
  • FIG. 54 Asia Pacific Women's Health Market Attractiveness Analysis, by Disease Indication, 2017-2025
  • FIG. 55 Latin America Women's Health Market Size (US$ Mn) and Y-o-Y (%) Forecast, 2015-2025
  • FIG. 56 Latin America Women's Health Market Attractiveness Analysis, by Country, 2017-2025
  • FIG. 57 Latin America Women's Health Market Value Share Analysis, by Country, 2016 and 2025
  • FIG. 58 Latin America Women's Health Market Value Share Analysis, by Treatment Type, 2016 and 2025
  • FIG. 59 Latin America Women's Health Market Value Share Analysis, by Disease Indication, 2016 and 2025
  • FIG. 60 Latin America Women's Health Market Attractiveness Analysis, by Treatment Type, 2017-2025
  • FIG. 61 Latin America Women's Health Market Attractiveness Analysis, by Disease Indication, 2017-2025
  • FIG. 62 Middle East & Africa Women's Health Market Size (US$ Mn) and Y-o-Y (%) Forecast, 2015-2025
  • FIG. 63 Middle East & Africa Women's Health Market Attractiveness Analysis, by Country, 2017-2025
  • FIG. 64 Middle East & Africa Women's Health Market Value Share Analysis, by Country, 2016 and 2025
  • FIG. 65 Middle East & Africa Women's Health Market Value Share Analysis, by Treatment Type, 2016 and 2025
  • FIG. 66 Middle East & Africa Women's Health Market Value Share Analysis, by Disease Indication, 2016 and 2025
  • FIG. 67 Middle East & Africa Women's Health Market Attractiveness Analysis, by Treatment Type, 2017-2025
  • FIG. 68 Middle East & Africa Women's Health Market Attractiveness Analysis, by Disease Indication, 2017-2025
  • FIG. 69 Competitive Positioning, 2016
  • FIG. 70 Breakdown of Net Sales, by Region, 2016
  • FIG. 71 Revenue (US$ Mn) and Y-o-Y Growth (%), 2013-2016
Back to Top